Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Total Current Liabilities (2016)

Lixte Biotechnology Holdings' Total Current Liabilities history spans 7 years, with the latest figure at $195577.0 for Q3 2016.

  • For Q3 2016, Total Current Liabilities fell 11.97% year-over-year to $195577.0; the TTM value through Sep 2016 reached $195577.0, down 11.97%, while the annual FY2015 figure was $285642.0, N/A changed from the prior year.
  • Total Current Liabilities reached $195577.0 in Q3 2016 per LIXT's latest filing, up from $139555.0 in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $467124.0 in Q1 2012 to a low of $139555.0 in Q2 2016.
  • Average Total Current Liabilities over 5 years is $276618.7, with a median of $268076.5 recorded in 2013.
  • Peak YoY movement for Total Current Liabilities: soared 37.07% in 2014, then crashed 44.77% in 2015.
  • A 5-year view of Total Current Liabilities shows it stood at $261152.0 in 2012, then grew by 23.21% to $321774.0 in 2013, then rose by 25.03% to $402319.0 in 2014, then decreased by 29.0% to $285642.0 in 2015, then plummeted by 31.53% to $195577.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Total Current Liabilities are $195577.0 (Q3 2016), $139555.0 (Q2 2016), and $192615.0 (Q1 2016).